Autoimmunity to endoplasmic reticulum chaperone GRP94 in myasthenia gravis

Journal of Neuroimmunology

Volumn 237, Issue 1-2, 2011, Pages 87-92

  Suzuki, Shigeaki ^a   Utsugisawa, Kimiaki ^b   Iwasa, Kazuo ^c   Satoh, Takashi ^a   Nagane, Yuriko ^b   Yoshikawa, Hiroaki ^c   Kuwana, Masataka ^a   Suzuki, Norihiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hanamaki General Hospital   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Autoantibody; Autoimmune diseases; ER stress; GRP94; Immunoprecipitation; Myasthenia gravis

Indexed keywords

AUTOANTIBODY; GLUCOSE REGULATED PROTEIN 94;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MYASTHENIA GRAVIS; PREVALENCE; PRIORITY JOURNAL;

ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR CHAPERONES; MYASTHENIA GRAVIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80051472908     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.06.011     Document Type: Article

References (20)

1. Boehm J., Orth T., Van Nguyen P., Soling H.D. Systemic lupus erythematosus is associated with increased auto-antibody titers against calreticulin and grp94, but calreticulin is not the Ro/SS-A antigen. Eur. J. Clin. Invest. 1994, 24:248-257.
2. Corrigall V.M., Bodman-Smith M.D., Fife M.S., Canas B., Myers L.K., Wooley P., Soh C., Staines N.A., Pappin D.J., Berlo S.E., van Eden W., van Der Zee R., Lanchbury J.S., Panayi G.S. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J. Immunol. 2001, 166:1492-1498.
3. Evoli A., Minicuci G.M., Vitaliani R., Battaglia A., Della Marca G., Lauriola L., Fattorossi A. Paraneoplastic diseases associated with thymoma. J. Neurol. 2007, 254:756-762.
4. Iwasa K., Kato-Motozaki Y., Furukawa Y., Maruta T., Ishida C., Yoshikawa H., Yamada M. Up-regulation of MHC class I and class II in the skeletal muscles of myasthenia gravis. J. Neuroimmunol. 2010, 225:171-174.
5. Jaretzki A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology 2000, 55:16-23.
6. Kuks J.N.M., Oosterhuis H.J.G.H. Clinical Presentation and Epidemiology of Myasthenia Gravis. Myasthenia gravis and related disorders 2003, 93-113. Humana Press, New Jersey. H.J. Kaminski (Ed.).
7. Kuwana M., Kimura K., Kawakami Y. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. Arthritis Rheum. 2002, 46:2742-2747.
8. Liu B., Dai J., Zheng H., Stoilova D., Sun S., Li Z. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15824-15829.
9. Meriggioli M.N., Sanders D.B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009, 8:475-490.
10. Nagaraju K., Casciola-Rosen L., Lundberg I., Rawat R., Cutting S., Thapliyal R., Chang J., Dwivedi S., Mitsak M., Chen Y.W., Plotz P., Rosen A., Hoffman E., Raben N. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 2005, 52:1824-1835.
11. Ozaki K., Inoue K., Sato H., Iida A., Ohnishi Y., Sekine A., Sato H., Odashiro K., Nobuyoshi M., Hori M., Nakamura Y., Tanaka T. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 2004, 429:72-75.
12. Pagetta A., Folda A., Brunati A.M., Finotti P. Identification and purification from the plasma of Type 1 diabetic subjects of a proteolytically active Grp94Evidence that Grp94 is entirely responsible for plasma proteolytic activity. Diabetologia 2003, 46:996-1006.
13. Purcell A.W., Todd A., Kinoshita G., Lynch T.A., Keech C.L., Gething M.J., Gordon T.P. Association of stress proteins with autoantigens: a possible mechanism for triggering autoimmunity?. Clin. Exp. Immunol. 2003, 132:193-200.
14. Suzuki S., Satoh T., Yasuoka H., Hamaguchi Y., Tanaka K., Kawakami Y., Suzuki N., Kuwana M. Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. J. Neuroimmunol. 2005, 170:141-149.
15. Suzuki S., Utsugisawa K., Yoshikawa H., Motomura M., Matsubara S., Yokoyama K., Nagane Y., Maruta T., Satoh T., Sato H., Kuwana M., Suzuki N. Autoimmune targets of heart and skeletal muscles in myasthenia gravis. Arch. Neurol. 2009, 66:1334-1338.
16. Todd D.J., Lee A.H., Glimcher L.H. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat. Rev. Immunol. 2008, 8:663-674.
17. Turner M.J., Delay M.L., Bai S., Klenk E., Colbert R.A. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum. 2007, 56:215-223.
18. Vattemi G., Engel W.K., McFerrin J., Askanas V. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am. J. Pathol. 2004, 164:1-7.
19. Wiendl H., Hohlfeld R., Kieseier B.C. Immunobiology of muscle: advances in understanding an immunological microenvironment. Trends Immunol. 2005, 26:373-380.
20. Zhang K., Kaufman R.J. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 2006, 66:S102-S109.